In the following, we selected 25 invasive breast carcinoma cases whose HER2 biomarker expression ranged across a large range of values known by routine diagnostics, as assessed by the two conventional methods used (i.e.: IHC and FISH), and for which several cases presented equivocal results. The gene discussed is ERBB2; the disease is invasive breast carcinoma.